ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugPharvaris GmbH
Pharvaris GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Pharvaris GmbH is a late‑stage biopharmaceutical company developing novel oral bradykinin B2‑receptor antagonists. The company focuses on bradykinin‑mediated diseases, including hereditary angioedema (HAE) and acquired angioedema due to C1‑inhibitor deficiency, and is developing deucrictibant in immediate‑release and extended‑release formulations for on‑demand and prophylactic treatment.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
Development of oral therapies for bradykinin-mediated angioedema
Development of investigational oral therapies based on bradykinin B2 receptor antagonists for bradykinin-mediated angioedema, in particular hereditary angioedema and AAE-C1INH.
Clinical development of Deucrictibant
Investigational orally administered bradykinin B2 receptor antagonist in clinical development for prevention and acute treatment of HAE and AE-BK attacks.
Prevention of HAE attacks
Once-daily oral extended-release tablet with Deucrictibant for prevention of HAE attacks; therapeutic exposure over 24 hours and Phase 3 development.
On-demand treatment of HAE attacks
Oral immediate-release capsule with Deucrictibant for the rapid treatment of HAE attacks; therapeutic exposure within 15–20 minutes and Phase 3 development.
Development of therapies for AAE-C1INH
Development of treatment approaches for acquired angioedema due to C1-INH deficiency as a bradykinin-mediated disease within the clinical pipeline.
Scientific publications
Publications of scientific findings and research data, available via the publication overview.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Pharvaris GmbH

Trust & reputation

ranQ Trust Score of Pharvaris GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Pharvaris GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Pharvaris GmbH scores 73.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Pharvaris GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Pharvaris GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Pharvaris GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Pharvaris GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Pharvaris GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Pharvaris GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Pharvaris GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grafenauweg 8
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-462.641.977
Founded
2020 · 6 years
Last commercial register change
January 17, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    KP
    KalVista Pharmaceuticals Switzerland GmbH
    Zug
    AP
    Aphaia Pharma AG
    Zug
    BM
    Blueprint Medicines (Switzerland) GmbH
    Zug
    NI
    Noveeda International GmbH
    Zug
    EB
    Enable Biotech AG
    Zug
    CA
    Cellis AG
    Zug
    C(
    Cytokinetics (Switzerland) GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug